GlassScriptPhysician profile
Catherine S Schuller
NPI 1649405820
$2,513.29
in general payments reported to CMS, 2019-2025
28 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $48.72 · 2021: $281 · 2022: $615 · 2023: $444 · 2024: $201 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865 · Education: $82.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.96 |
| Education | $82.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $483.96 | 2019-2023 | Mara Console |
| Abbvie INC. | $434.73 | 2019-2025 | Liletta, Lo Loestrin Fe, Orilissa |
| Ethicon US, LLC | $166.11 | 2021 | |
| Astellas Pharma US INC | $160.31 | 2019-2024 | Veozah |
| Hologic Sales and Service, LLC | $151.58 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $142.51 | 2019-2024 | |
| Biogen, INC. | $123.54 | 2025 | Zurzuvae |
| Medicem INC. | $104.29 | 2022 | |
| Amgen INC. | $82.74 | 2019-2024 | Evenity, Prolia |
| Alydia Health | $81.82 | 2021 | |
| Myriad Women'S Health, INC. | $75.57 | 2023 | Myrisk |
| Pfizer INC. | $74.95 | 2019-2024 | |
| Organon LLC | $71.82 | 2022-2025 | Nexplanon |
| Therapeuticsmd, INC. | $57.22 | 2019-2022 | |
| Daiichi Sankyo INC. | $47.29 | 2023 | Injectafer |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $35.29 | 2025 | Myfembree |
| Merck Sharp & Dohme LLC | $26.88 | 2019-2022 | |
| Minerva Surgical, INC | $22.78 | 2019 | |
| Amag Pharmaceuticals, INC. | $22.60 | 2020 | |
| Lilly USA, LLC | $20.63 | 2025 | Zepbound, Mounjaro |
| Convatec INC. | $19.27 | 2023 | |
| Shield Therapeutics INC | $18.87 | 2023 | Accrufer |
| Inspire Medical Systems, INC. | $17.78 | 2025 | Inspire |
| Baxter Healthcare | $16.20 | 2025 | Tisseel |
| Avion Pharmaceuticals | $15.55 | 2022 | |
| Smith+Nephew, INC. | $13.60 | 2019 | |
| Axonics, INC. | $12.87 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Schuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.